Mon - Fri 9AM-5PM +1-407-776-9217

Through advancements in science, medicine, and genomics, we aim
to improve the lives of patients who suffer from cancer and other
debilitating diseases.

Diverse Biotech is a biopharmaceutical research company, focused on new medical discoveries and the development of new molecules for the treatment of disease. Commercialization path of these new discoveries include;

  1. Our continuous commitment to follow the FDA New Drug Application for commercialization.
  2. Identifying synergies with bio-pharma companies, for the ongoing development of new assets in oncology, dermatology and inflammatory therapeutic indications.
  3. Creating collaborations around licensing opportunities

Diverse DNA is a wholly owned subsidiary that is at the forefront of early cancer detection and transforming patient care through advanced personalized genomic testing so patients can make better lifestyle decisions.

DIVERSE BIOTECH

is focused on drug-discovery and development

DIVERSE DNA

is focused on cancer screening and pharmacogenomic programs

We Are Committed To Making A Difference In Cancer Treatment

Each day, countless lives around the world are devastated by cancer diagnoses. We want to make a difference and develop novel treatments that save lives and give people hope.